Authors:
Giraud, M
Beaurain, G
Yamamoto, AM
Eymard, B
Tranchant, C
Gajdos, P
Garchon, HJ
Citation: M. Giraud et al., Linkage of HLA to myasthenia gravis and genetic heterogeneity depending onanti-titin antibodies, NEUROLOGY, 57(9), 2001, pp. 1555-1560
Authors:
Yamamoto, AM
Chernajovsky, Y
Lepault, F
Podhajeer, O
Feldmann, M
Bach, JF
Chatenoud, L
Citation: Am. Yamamoto et al., The activity of immunoregulatory T cells mediating active tolerance is potentiated in nonobese diabetic mice by an IL-4-based retroviral gene therapy, J IMMUNOL, 166(8), 2001, pp. 4973-4980
Authors:
Yamamoto, AM
Gajdos, P
Eymard, B
Tranchant, C
Warter, JM
Gomez, L
Bourquin, C
Bach, JF
Garchon, HJ
Citation: Am. Yamamoto et al., Anti-titin antibodies in myasthenia gravis - Tight association with thymoma and heterogeneity of nonthymoma patients, ARCH NEUROL, 58(6), 2001, pp. 885-890
Authors:
Duclos-Vallee, JC
Johanet, C
Sebagh, M
Samuel, D
Yamamoto, AM
Citation: Jc. Duclos-vallee et al., Autoimmune hepatitis: mecanisms, clinical, pathological and therapeutic features, ANN MED IN, 152(6), 2001, pp. 371-382
Authors:
Cacoub, P
Renou, C
Rosenthal, E
Cohen, P
Loury, I
Loustaud-Ratti, V
Yamamoto, AM
Camproux, AC
Hausfater, P
Musset, L
Veyssier, P
Raguin, G
Piette, JC
Citation: P. Cacoub et al., Extrahepatic manifestations associated with hepatitis C virus infection - A prospective multicenter study of 321 patients, MEDICINE, 79(1), 2000, pp. 47-56
Authors:
Yamamoto, AM
Amoura, Z
Johannet, C
Jeronimo, ALC
Campos, H
Koutouzov, S
Piette, JC
Bach, JF
Citation: Am. Yamamoto et al., Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases - New tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases, ARTH RHEUM, 43(3), 2000, pp. 689-698
Authors:
Herzog, D
Yamamoto, AM
Jara, P
Maggiore, G
Sarles, J
Alvarez, F
Citation: D. Herzog et al., Sera of children with hepatitis C infection and anti-liver-kidney microsome-1 antibodies recognize different CYP2D6 epitopes than adults with LKM plus /HCV plus sera, J PED GASTR, 29(5), 1999, pp. 551-555
Authors:
Yamamoto, AM
Deschamps, I
Garchon, HJ
Roussely, H
Moreau, N
Beaurain, G
Robert, JJ
Bach, JF
Citation: Am. Yamamoto et al., Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children, J AUTOIMMUN, 11(6), 1998, pp. 643-650